FDA inspection
Centaur Pharmaceuticals Private Ltd.: FDA inspection ending Nov 21, 2022
FDA inspection 1192256 · Official Action Indicated (OAI) · Thane
Key facts
| Inspection ID | 1192256 |
|---|---|
| Firm | Centaur Pharmaceuticals Private Ltd. |
| FEI number | 3003973520 |
| Address | 76&76/1 Plots 75, Chikhloli Midc |
| City | Thane |
| Country | India |
| Fiscal year | 2023 |
| Inspection end date | Nov 21, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 651080 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data